Our findings revealed lower SLC7A11, GSH, and GPX4 in the livers of HFD mice and FFA-treated hepatocytes, suggesting an imbalance in the System Xc-/GSH/GPX4 pathway in NASH models. This evidence concerns the gene SLC7A11 and metabolic dysfunction-associated steatohepatitis.